DocuSign (NASDAQ:DOCU) Releases Earnings Results, Beats Expectations By $0.17 EPS

DocuSign (NASDAQ:DOCU) issued its earnings results on Thursday. The company reported $0.97 EPS for the quarter, beating analysts’ consensus estimates of $0.80 by $0.17, Briefing.com reports. The business had revenue of $736.03 million during the quarter, compared to analysts’ expectations of $727.20 million. DocuSign had a net margin of 3.81% and a return on equity of 15.44%. The company’s quarterly revenue was up 7.0% compared to the same quarter last year. During the same period in the prior year, the business earned $0.09 earnings per share. DocuSign updated its FY 2025 guidance to EPS and its Q3 2025 guidance to EPS.

DocuSign Trading Up 4.0 %

Shares of NASDAQ:DOCU opened at $59.19 on Friday. The company has a market capitalization of $12.12 billion, a price-to-earnings ratio of 113.83, a PEG ratio of 9.74 and a beta of 0.93. DocuSign has a 12-month low of $38.11 and a 12-month high of $64.76. The business has a 50-day moving average price of $55.44 and a 200 day moving average price of $55.86.

Insider Buying and Selling at DocuSign

In other DocuSign news, CEO Allan C. Thygesen sold 7,725 shares of DocuSign stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $59.09, for a total transaction of $456,470.25. Following the completion of the sale, the chief executive officer now directly owns 102,193 shares in the company, valued at $6,038,584.37. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In other DocuSign news, CEO Allan C. Thygesen sold 7,725 shares of the company’s stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $59.09, for a total transaction of $456,470.25. Following the transaction, the chief executive officer now directly owns 102,193 shares in the company, valued at $6,038,584.37. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Daniel D. Springer sold 287,052 shares of the firm’s stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $53.78, for a total value of $15,437,656.56. Following the transaction, the director now owns 923,445 shares of the company’s stock, valued at $49,662,872.10. The disclosure for this sale can be found here. Insiders have sold 482,418 shares of company stock valued at $25,524,100 over the last 90 days. 1.66% of the stock is owned by insiders.

Wall Street Analyst Weigh In

DOCU has been the subject of several research reports. Morgan Stanley dropped their price objective on shares of DocuSign from $65.00 to $62.00 and set an “equal weight” rating for the company in a research note on Friday, June 7th. Needham & Company LLC restated a “hold” rating on shares of DocuSign in a research report on Friday. Royal Bank of Canada lifted their price objective on DocuSign from $52.00 to $57.00 and gave the stock a “sector perform” rating in a research report on Friday. Wells Fargo & Company upped their target price on DocuSign from $48.00 to $50.00 and gave the company an “underweight” rating in a report on Friday. Finally, JMP Securities reiterated a “market outperform” rating and set a $84.00 price target on shares of DocuSign in a report on Thursday. Two equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $61.45.

DocuSign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.